Informing HEOR Models with Primary Market Research in Rare Diseases

admin — Mon, 19 Jan 2026 08:12:03 +0000

HEOR models are only as credible as the inputs behind them. In rare diseases, those inputs are frequently incomplete: natural history is poorly characterized, endpoints are inconsistent, and small, fragmented patient populations amplify uncertainty in both clinical and economic parameters (Grand et
al., 2024; Pearson et al., 2018).

The post Informing HEOR Models with Primary Market Research in Rare Diseases appeared first on MedPanel.

Primary Market Research Illuminates Endpoints in Rare Disease RWE

admin — Wed, 12 Nov 2025 18:29:53 +0000

Real-world evidence (RWE) underpins modern health economics and outcomes research (HEOR), especially when traditional clinical trials are infeasible in rare diseases. Small patient populations, varying symptoms, and uncertain etiology can limit trial insight and complicate endpoint selection.

The post Primary Market Research Illuminates Endpoints in Rare Disease RWE appeared first on MedPanel.

Inside Insights Archives - MedPanel

Informing HEOR Models with Primary Market Research in Rare Diseases

Primary Market Research Illuminates Endpoints in Rare Disease RWE